Some justices may be skeptical of a bid by GSK, Pfizer and others to overturn ruling allowing lawsuits to proceed over claims ...

Q4 2024 Earnings Call Transcript April 10, 2025 CureVac N.V. misses on earnings expectations. Reported EPS is $-0.16564 EPS, ...

The CDC's Advisory Committee on Immunization Practices (ACIP) voted 14-0, with one abstention, on Wednesday to recommend that ...

Significant delays in core FDA functions — such as approving amendments to clinical trials and guiding companies through ...

Environmental contributors to autism are behind its rising prevalence, U.S. Health Secretary Robert F. Kennedy Jr. said on ...

The Trump administration is considering eliminating dozens of programs at HHS amid a mass reorganization of the agency.

The S&P 500 rose 0.13% to close at 5,282.70 on Thursday (April 17) after a volatile trading session, though the index still ...

As first quarter earnings begin, executives are confronting market turmoil, regulatory instability and the threat of U.S.

With a portfolio containing a number of vaccines, GSK has been working for some years on the question of adult vaccination and why immunisation rates are falling, particularly in those over 50 ...

When Novartis announced it was teaming up with the NFL last month, the company called it the first-ever corporate pharmaceutical partnership with the league. But it wasn’t exactly the only matchup ...

A key group of government advisers voted to expand the use of vaccines for a common respiratory illness, providing a boost to ...

In the meantime, have a read of Emma Hanrahan’s piece on the Kingspan chief receiving backing from investor advisory firm ...